Summit Therapeutics Inc.SMMTNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average, strong compound growth.
Left:
||||
Year-over-year earnings per share growth rate
Latest
68.69%
↑ 251% above average
Average (9y)
-45.35%
Historical baseline
Range
High:168.75%
Low:-406.67%
CAGR
+34.9%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | 68.69% |
| 2023 | -141.46% |
| 2022 | 57.29% |
| 2021 | -26.32% |
| 2020 | -406.67% |
| 2019 | -236.36% |
| 2018 | 168.75% |
| 2017 | 62.79% |
| 2016 | -4.88% |
| 2015 | 4.65% |